Heparin Inhibition of the Cytostatic Effect of Adriamycin® on Cultured Lymphocytes

Abstract
The cytostatic effects of Adriamycin® on PHA-stimulated lymphocyte incubates are inhibited by the simultaneous administration of heparin. Simultaneous administration of heparin, therefore, might also interfere with the tumoricidal effect of Adriamycin® in patients receiving antitumor therapy.

This publication has 0 references indexed in Scilit: